外科治疗胃大部切除术后食管癌12例报告

目的　探讨胃大部切除术后食管癌的手术方式。方法　对 10例单纯胃大部切除术后食管癌和 2例胃大部切除 +脾切除术后食管癌采用两种不同术式。结果　两种术式均取得成功 ,无吻合口瘘及切缘癌残留发生。结论　残胃与脾胰体尾联合移入胸腔与食管吻合治疗单纯胃大部切除术后食管癌是一种可靠、实用的手术方法 ;以回结肠动脉为供血管 ,末段回肠 +右半结肠代食管术 ,治疗胃大部切除 +脾切除术后食管癌有其临床可行性     

残胃贲门癌和食管癌的外科术式选择

目的 探讨残胃贲门癌和食管癌的外科术式选择及处理要点。方法 1991-2003年间18例残胃贲门癌和食管癌患者，其中食管中段癌3例，食管下段癌2例，贲门癌13例。行残胃代食管2例，结肠代食管3例，空肠代食管胃13例。结果 全部治疗病例中术后吻合口瘘1例，17天死亡，上切缘阳性1例。1年生存率72.2%(14/18)。3年生存率50%（9/18）。结论 结肠代食管是颈部吻合较理想的选择。胸腔内吻合可视具体情况选择残胃、空肠代部分食管及胃。     

外科治疗胃大部切除术后食管癌12例报告

目的：探讨胃大部切除术后食管癌的手术方式。方法：对10例单纯胃大部切除术后食管癌和2例胃大部切除 脾切除术后食管癌采用两种不同术式。结果：两种术式均取得成功，无吻合口瘘及切缘癌残留发生。结论：残胃与脾胰体尾联合移入胸腔与食管吻合治疗单纯胃大部切除术后食管癌是一种可靠、实用的手术方法；以回结肠动脉为供血管，末段回肠 右半结肠代食管术，治疗胃大部切除 脾切除术后食管癌有其临床可行性。     

结肠代食管术12例临床分析

目的 探讨结肠代食管术在消化道重建中的应用价值.方法 12例中,8例为食管癌术后吻合口复发,3例为食管癌既往有胃大部切除病史,1例为食管癌术后吻合口狭窄放置支架后吻合口气管瘘.9例采用横结肠加部分降结肠代食管,左结肠动脉为供血血管,顺蠕动吻合;3例采用横结肠加部分升结肠代食管,中结肠动脉为供血血管,逆蠕动吻合.结果 全...     

经食管床食管胃弓上器械吻合治疗食管癌

目的总结食管癌切除手术中应用吻合器行经食管床食管胃弓上器械吻合的临床经验.方法全组食管癌46例,其中食管胸中段癌32例,胸下段癌11例,胸上段癌3例.全部经左胸后外侧切口行食管癌切除,术中采用国产WGW-Ⅱ型消化道吻合器,行经食管床食管胃弓上吻合.结果全组手术吻合顺利,无术后死亡、吻合口瘘及明显吻合口狭窄.结论经食管床食管胃弓上器械吻合治疗食管癌具有扩大切除范围、降低术后并发症的优点,值得推广.     

结肠代食管12例报告

1984年至1994年，丽水地区医院对胃大部切除后12例食管癌行胸骨后径路结肠代食管颈部吻合，无吻合口并发症。现就手术方式及适应证介绍如下：1临床资料12例中男周例，女2例。年龄50岁～62岁，平均55岁。8例胃大部如除术后发生食管癌的时间距首次手术8年～12年，平均9年，其中毕罗氏Ⅱ式结肠后吻合6例，结肠前吻合2例。癌灶长度2cm～6cm，病理报告均为鳞癌。手术方式：左颈、右胸、上腹三切口，取结肠左动脉升支为供血管，截取横结肠和结肠脾曲作为代食管的器官，按顺蠕动方向通过胸骨后一层间断颈部端端吻合、腹部结肠胃端侧吻合、残留结肠…     

胃大部切除后食管癌和贲门癌的外科治疗——附24 例报告

目的：探讨胃大部切除术后食管癌和贲门癌的手术方式、处理要点和预后。方法：１９８９ 年１ 月～１９９７ 年１２ 月２４ 例胃大部切除术后食管癌和贲门癌患者实行手术治疗,其中食管癌１５ 例,贲门癌９例。残胃代食管３ 例,空肠代食管胃７ 例,回结肠代食管胃５ 例,结肠代食管胃经胸骨后颈部吻合９ 例。结果：胸腔内吻合１５ 例,１ 例发生吻合漏（６ ．７ ％ ） ,第１９ 天死亡,颈部吻合９ 例,２ 例发生吻合口漏（２２ ．２ ％ ） ,无死亡。１ 年生存率为８６ ．７ ％ ,３ 年生存率为５３ ．３ ％ 。结论：结肠经胸骨后代食管胃是颈部吻合较理想的选择,胸腔内吻合可视具体情况选择残胃、空肠、回结肠代食管胃。     

食管癌贲门癌切除及食管(管状胃)胃侧侧吻合术

目的探讨食管癌、贲门癌切除、食管(管状胃)胃侧侧吻合术的治疗效果及应用前景。方法共有32例患者行此手术。贲门癌6例、食管癌26例;其中胸下段9例,胸中段12例,胸上段5例。术中按肿瘤手术切除原则常规游离食管及近端胃,切除肿瘤。行主动脉弓下吻合9例,经食管床主动脉弓上吻合10例,左胸左颈两切口4例,右胸顶吻合3例,右胸颈腹三切口6例。22例患者应用管状胃代食管,10例患者应用全胃代食管。行食管胃端端吻合+侧侧吻合术15例;食管胃端侧吻合+侧侧吻合术10例;胸下段食管癌患者行食管管状胃全侧侧吻合术7例。结果本组病例术后分期分别为Ⅱa期9例,Ⅱb期11例,Ⅲ期12例。全部病例手术顺利,术后未出现吻合口瘘,术后2周复查上消化道钡透及胃镜检查均见吻合口通畅、无狭窄,术后随诊0.5～2年不等,均未见吻合口狭窄。结论食管癌、贲门癌切除食管(管状胃)胃侧侧吻合术可降低吻合口并发症尤其是狭窄的发生,值得临床推广。     

食管胃(超)胸膜顶吻合术治疗食管癌

目的 :探讨食管癌合理的手术方式。方法 :对食管中下段癌行食管部分切除 ,食管胃 (超 )胸膜顶吻合 2 10例 ,与弓上吻合 880例的资料进行回顾性对比分析。结果 :两组术后吻合口瘘发生率基本相同 ,但胸膜顶组其他并发症少 ,残端癌发生率低。结论 :胃食管 (超 )胸膜顶吻合术是治疗食管癌的理想术式     

消化道吻合器颈部食管胃吻合治疗食管癌346例临床报告

目的探讨次全食管切除胃经食管床消化道吻合器颈部食管胃吻合治疗食管癌的手术效果。方法346例食管癌患者采用左后外侧六肋间切口,游离肿瘤并行次全食管切除,清扫肿大淋巴结。取左颈部胸锁乳突肌前缘切口,游离颈段食管,将胃经食管床主动脉弓后上置颈部,行食管胃消化道吻合器吻合。分析该手术及效果。结果术后残端癌4例,发生率为1.2%。吻合口瘘19例,发生率为5.5%。术后死亡1例,死亡率为O.6%。吻合口狭窄13例,发生率为3.8%,均经食管扩张治愈。结论该术式符合肿瘤彻底切除的原则,残端癌阳性率低。胃放置于食管床内对呼吸循环影响小。使用吻合器增加了吻合的可靠性,减少了术后并发症。即使发生了吻合口瘘,处理也相对简单,死亡率低。     

食管癌穿孔外科治疗的临床分析

背景与目的:食管癌穿孔往往发生在癌肿进展期,易并发胸内感染,病情危重。保守疗法包括食管旷置、肠内或静脉营养支持以及内镜下放置支架,但是这些方法既不能消除癌肿又难以控制胸内感染,近期死亡率高。本研究分析外科治疗食管癌穿孔的手术方法及围手术期治疗特点。方法:对41例食管癌穿孔患者(其中穿入右肺19例,穿入纵隔17例,穿入气管5例)进行手术治疗。开胸手术39例,其中右胸三切口术式16例,分期手术23例,经胸骨后间隙胃或结肠代食管35例,经食管床胃代食管4例。2例只做胃造瘘姑息手术治疗。结果:36例患者获得手术成功,康复期能经口腔进食保证营养,生活自理,术后随访3～72个月,其中生存3个月2例,6～12个月31例,24个月2例,72个月1例,手术后死亡2例,2例胃造瘘姑息手术者和1例术后吻合口气管瘘再通者自动出院后1个月内死亡。结论:手术治疗食管癌穿孔成功恢复消化道的连续性,明显延长了患者的生存期,提高了生活质量;手术径路以右胸三切口术式(胸骨后胃或结肠代食管)或分期手术为佳。     

管状胃在食管贲门癌手术中的临床应用

目的：评价管状胃技术在食管、贲门癌患者根治手术中的临床效果。方法：选取2007年5月-2010年12月我院胸外科收治的食管、贲门癌214例,按手术方法分为管状胃组和对照组,管状胃组：118例,男99例,女19例,年龄58.81±8.39岁（38-80岁）。其中食管癌104例于左颈部吻合49例,弓上吻合32例,弓下吻合23例;贲门癌根治14例。对照组：96例,男74例,女22例,年龄58.54±9.05岁（27-80岁）。食管癌89例于左颈部吻合8例,主动脉弓上吻合56例,弓下吻合25例;贲门癌根治7例。观察两组术后吻合口瘘发生率、手术时间、住院时间等。结果：两组均顺利完成手术。管状胃组发生吻合口瘘1例,残胃瘘7例;对照组发生吻合口瘘4例,残胃瘘1例;手术时间管状胃组与对照组（257.77±79.77 min vs 244.26±63.68 min,t=1.342,P=0.181）,吻合口瘘（P〉0.05）及残胃瘘（P〉0.05）差异无统计学意义,术后住院时间（14.90±5.65d vs 17.20±8.49d,t=2.279,P=0.024）,胸胃综合症发生率（P〈0.05）差异有统计学意义。结论：管状胃操作简单、安全,胸胃综合症并发症发生率较低,不增加手术时间,缩短了住院时间,可改善患者术后生活质量,具有较好的临床应用价值。     

Five cases of early gastric cancer in the reconstructed gastric tube after radical resection for esophageal cancer

We report seven early gastric cancers in five patients, which arose in the reconstructed gastric tube after radical resection for esophageal cancer. Four of them occurred in the middle gastric tube and three in the distal gastric tube. Three of 5 cases were reconstructed via the retromediastinal route and two via the presternal route. They all were diagnosed by follow-up endoscopy from 8 months to 5 years after esophagectomy. All of them were treated surgically with partial resection of the gastric tube because they were suspected to have invaded the submucosal layer or large enough to be treated with endoscopic mucosal resection (EMR). Histologically, six of seven were diagnosed as well differentiated adenocarcinoma and one as signet ring cell carcinoma. Although one of them died for reasons other than cancer itself, the others are alive and well without any recurrence. Recently, gastric tube cancer after esophagectomy has been increasingly reported to be accompanied with prolongation of survival of esophageal cancer patients. Total or partial gastrectomy is proposed for surgical treatment of gastric tube cancer, but the operating procedure is complicated and invasive, especially in the case of gastric tube reconstructed via the retromediastinal route. Total gastrectomy is much more invasive because it needs re-reconstruction with other organs. Therefore, it is important to detect the lesion in early stages so as to treat it with minimally invasive surgery such as EMR or partial resection. Hence intensive follow up with endoscopy is necessary after resection of esophageal cancer.     

急性梗阻性左半结肠癌I期切除吻合59例治疗分析

目的：探讨左半结肠癌并急性梗阻行I期切除吻合术的安全性和可行性。方法：回顾性分析59例急性梗阻性左半结肠癌手术治疗患者的临床资料。结果：结肠脾曲癌11例,降结肠癌34例,乙状结肠癌14例,行I期结肠癌切除吻合术53例,Hartmann手术3例,单纯近端结肠造瘘3例。无死亡病例,吻合口瘘2例。结论：正确掌握急性梗阻性左半结肠癌手术时机、灌洗方法,合理选择手术方式,做好围手术期处理,尽量选择I期切除吻合术是安全可行的。     

食管中段癌切除吻合口部位的选择

作者对１６４例食管中段癌作了切除术，其中颈部食管胃吻合术３９例，上下切缘无残留癌，发生吻合口瘘４例，均治愈，胸内食管胃弓上吻合１２５例，发生吻合口瘘６例死亡１例，上切缘残留癌１０例，作者对颈部和胸内两种部位吻合作了比较和分析，认为食管中段癌苇除颈部吻合利弊少，切除长度足够，无残留癌组织，即使发生了吻合口瘘，治疗也容易，大多能痊出院。     

A clinicopathological study on carcinoma of the gastric stump, with special reference to mucosal change

Ten carcinomas of the gastric stump reconstructed by Billroth I (one case) and Billroth II (9 cases) methods were treated an average of 20 (range: 7-46) years after partial gastrectomy. Because of highly advanced carcinoma, total gastrectomy with resection of invaded organs was performed. The 5-year survival rate was 33%, and was not different from that in patients with carcinoma of the cardia. Thus, the prognosis of gastric stump carcinoma was not poor if extended radical operation was carried out. The mucosa showed severe atrophic gastritis with intestinal metaplasia or atrophic and hypertrophic gastritis in patients with carcinoma. However, the mucosa was hyperplasia of the glands in almost all patients with stomal ulcer. Thus, our findings suggest that atrophic change with intestinalization plays a role in gastric carcinogenesis.     

102例老年食管癌术后呼吸功能不全的临床诊疗分析

目的:探讨老年食管癌术后呼吸功能不全的危险因素。方法:对102例老年食管癌术后呼吸功能不全的临床资料做回顾性分析。结果:在102例老年食管癌术后呼吸功能不全患者中,34例发生呼吸衰竭(占33.3%),12例死亡(占呼吸衰竭病例数的35.3%,占呼吸功能不全病例数的11.8%)。术后呼吸功能不全发生时间:从手术结束麻醉苏醒后不能脱呼吸机至术后10天,其中呼吸衰竭多发生于发生呼吸功能不全6~12小时后。呼吸衰竭患者应用呼吸机治疗时间为2~27天。结论:术前心肺功能较差、肺部原发疾病、术中输入较多晶体液、术中大量输血、手术创伤、术后切口疼痛、肺部感染、胸胃扩张、吻合口瘘、胃贲门残端瘘等与老年食管癌术后呼吸功能不全有关。     

Clinical management of gastric cancer and concomitant esophagogastric varices

We report the late results of treatment of 13 consecutive patients with gastric cancer and concomitant esophagogastric varices. Of seven good-risk patients classified as Child's class A or B, gastrectomy together with selective shunt operation was performed in two, total gastrectomy with splenectomy in three, and distal partial gastrectomy with paraesophageal devascularization without splenectomy in one. The remaining patient with early gastric cancer underwent distal partial gastrectomy following repeated endoscopic injection sclerotherapy (EIS) for treatment of the esophageal varices. Although the majority of patients who underwent surgical repair of varices (i.e., shunt, splenectomy, or devascularization) died, total gastrectomy with splenectomy was the only procedure that led to control of the esophageal varices. Since partial gastrectomy combined with EIS limits the morbidity and mortality of an extensive resection and at the same time controls esophageal variceal bleeding, it is probably the procedure of choice for patients with a carcinoma in the lower two-thirds of the stomach. Concerning non-surgical cases, two patients were effectively treated using laser endoscopy and EIS, without the occurrence of variceal bleeding. The remaining four patients, given chemotherapy or irradiation for treatment of gastric carcinoma, died within 4 months with variceal bleeding or liver failure. For the poor-risk patients with evidence of severe liver dysfunction, laser treatment and EIS would be the treatment of choice.